Biofrontera AG American Depositary Shares
BFRA
BFRA was delisted on the 4th of March, 2022.
5 hedge funds and large institutions have $5.33M invested in Biofrontera AG American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
19% less capital invested
Capital invested by funds: $6.59M → $5.33M (-$1.26M)
29% less funds holding
Funds holding: 7 → 5 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$633K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$6.07K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$708 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.07M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$19K |
BFRA Hedge Fund Activity: Q4 2018 in Review
5 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Biofrontera AG American Depositary Shares (BFRA) for Q4 2018, worth a combined $5.33M — down 19% from $6.59M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BFRA and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was Heartland Advisors, adding an estimated $633K. The largest seller was Opaleye Management, exiting entirely with an estimated $1.07M sold.
- 5 institutional investors held Biofrontera AG American Depositary Shares (BFRA) as of Q4 2018, down from 7 in Q3 2018.
- Funds reported $5.33M of Biofrontera AG American Depositary Shares stock for Q4 2018, down 19% quarter-over-quarter.
- 0 funds opened new Biofrontera AG American Depositary Shares positions in Q4 2018 and 2 closed out, a net change of -2 holders.
- The largest Biofrontera AG American Depositary Shares buyer in Q4 2018 was Heartland Advisors, an estimated $633K added.
- The largest Biofrontera AG American Depositary Shares seller in Q4 2018 was Opaleye Management, an estimated $1.07M sold.
Based on aggregated 13F filings for Q4 2018.